Jeffrey Sandman will be participating in the 2009 BIO International Convention taking place from May 18-21, 2009 in Atlanta, GA.

Mr. Sandman will act as Chair on a panel titled, "Communicating Your Story: Dual Path Exit Strategies."

This panel discussion will present a strategic communications blueprint for pharmaceutical and biotech firms struggling with an unstable international financial climate.  Featuring panelists representing venture capitalists, biotech and pharmaceutical companies and life science communications specialists, the presentations and panel members will engage in a dialogue about the communication challenges facing the biotech and pharmaceutical industries and how best to reach a wide array of stakeholders including investors, key opinion leaders, venture capitalists, consumers and other customers.

Objectives

  1. Provide a practical framework to communicate across all audiences around a dual path financial exit strategy
  2. Provide pharmaceutical and biotech firms the current state of play in the financial markets
  3. Share real world case experiences and best practices from an array of different perspectives

Chair

  • Jeffrey Sandman, JD, MPA
    CEO
    Hyde Park Communications

Speakers

  • Jeff Frick, MBA
    Chief Business Officer
    Agile Therapeutics, Inc
  • Robert Carey
    Managing Director, Healthcare Investment Banking
    JMP Securities LLC
  • Donna LaVoie
    President & CEO
    Lavoie Strategic Communications Group Inc
  • Corinne Savill, PhD
    Global Head, BD & L Search & Evaluation
    Novartis Institutes for Biomedical Research
  • Charles Rowland
    Vice President, Chief Financial Officer
    ViroPharma, Inc

For more information about the 2009 BIO International Convention, please visit http://convention.bio.org/.